This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the supply of TARPEYO 4MG, a specialized pharmaceutical product, to the VA's New York Harbor healthcare system. The contract has a ceiling value of $10,896.98 and a period of performance through July 31, 2025. The contract does not have a set-aside designation. Pantherx...
This federal contract award is for the supply of TARPEYO 4MG drug prescriptions to the New York Harbor Healthcare System, a division of the Department of Veterans Affairs (VA). The $10,897.20 firm fixed price purchase order was awarded to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. Pantherx Specialty is a specialized pharmacy focused on rare diseases and customized medications, and has established itself as a targeted provider of...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the delivery of TARPEYO 4mg (NDC 81749-0004-01), an emergency medical product, with a ceiling value of $10,896.98 and a period of performance ending on August 13, 2025. This contract does not have a...
This is a $10,897.20 firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is for the supply of TARPEYO 4MG CAPSULES, a medication used to treat rare diseases, to various VA healthcare facilities under the Veterans Integrated Service Network 2. Pantherx Specialty has received multiple federal purchase orders from the Department of Veterans...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Pantherx Specialty, LLC, a specialty pharmacy subsidiary of Centene Corporation. The contract is for the supply of the prescription medication Tarpeyo 4mg capsules to VA facilities within Veterans Integrated Service Network 2. The contract has a total ceiling value of $10,638.00 and runs through March 20, 2025. There is no set-aside designation associated...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network (VISN) 2, a civilian agency within the U.S. Department of Veterans Affairs (VA), to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the delivery of TARPEYO 4mg capsules to the New York Harbor, Margaret Cochran Corbin VA Medical Center. The contract has a ceiling value of $10,896.98 and a period of performance ending on...
This federal contract award, valued at $10,897.20, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the delivery of TARPEYO (budesonide) 4mg prescription medication to the New York Harbor. The contract is a firm fixed-price purchase order with a completion date of May 28, 2025. This contract does not have a...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the supply of TARPEYO (budesonide) 4mg prescription medication to the VA's Veterans Integrated Service Network (VISN) 2, which serves the New York Harbor region. The total ceiling value of the contract is $10,897.20, with a period of performance through May 2, 2025. The contract...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the pharmaceutical product Ruzurgi [amifampridine] to Veterans Integrated Service Network 16 facilities. The contract has a potential value of $119,339.01 and a completion date of September 30, 2020. Pantherx Specialty is a subsidiary of Centene Corporation that operates as a specialty pharmacy focused...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the drug Ruzurgi (amifampridine) 10 mg tablets with a potential value of $136,387.44. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialty pharmacy focused on rare diseases that has received multiple federal contract awards from the Department of Justice Bureau of Prisons and the...